Standout Papers

Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers 2018 2026 2020 2023 256
  1. Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers (2018)
    Anu Sharma, Sumit K. Subudhi et al. Clinical Cancer Research

Immediate Impact

16 by Nobel laureates 2 from Science/Nature 63 standout
Sub-graph 1 of 20

Citing Papers

The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
6 intermediate papers

Works of Jorge Scutti being referenced

Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2018 StandoutNobel

Author Peers

Author Last Decade Papers Cites
Jorge Scutti 262 237 41 4 315
Mariona Cabo 227 244 35 4 320
F Rojas Villegas 198 296 34 3 347
Mengjun Zhong 226 150 53 5 262
Yair Klieger 167 247 101 8 361
Laure Loumagne 179 282 55 4 347
Christopher Bricogne 205 197 114 7 346
Jenna L. Collier 146 196 61 5 287
Amelia Au‐Yeung 163 169 106 7 319
Jung Hyun Her 223 254 43 8 313
Ti Badri 185 172 48 5 310

All Works

Loading papers...

Rankless by CCL
2026